Evidence map›Paper›PMID 42092137›Full record

ArticleNature2026

HIV-1 signalling remodels nuclear pores to licence infection.

Dejan Mesner, Matthew V X Whelan, Maitreyi Shivkumar, Ann-Kathrin Reuschl, Riccardo Zenezini Chiozzi, Konstantinos Thalassinos, Robertus A M de Bruin, Clare Jolly

Abstract read
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dejan Mesner *Division of Infection and Immunity, University College London, London, United Kingdom.
Matthew V X Whelan *Division of Infection and Immunity, University College London, London, United Kingdom.
Maitreyi ShivkumarDivision of Infection and Immunity, University College London, London, United Kingdom.
Ann-Kathrin ReuschlDivision of Infection and Immunity, University College London, London, United Kingdom.
Riccardo Zenezini ChiozziInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, United Kingdom.
Konstantinos ThalassinosInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-5072-8428
Robertus A M de BruinLaboratory for Molecular Cell Biology, University College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-9957-1409
Clare JollyDivision of Infection and Immunity, University College London, London, United Kingdom. clare.jolly@qmul.ac.uk.ORCID http://orcid.org/0000-0002-4603-2281

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 is readily detected in resting CD4

Indexed as

HIV-1HIV InfectionsNuclear PoreSignal TransductionActive Transport, Cell NucleusCapsidCD4-Positive T-LymphocytesCDC2 Protein KinaseHumansNuclear Pore Complex ProteinsPhosphorylationCDC2 Protein KinaseNuclear Pore Complex Proteins

Identifiers

PMID42092137
PMCPMC13293875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.